Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab

Published:2018-05-18 Issue:1 Volume:60 Page:100-106
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Chiao Ping,Bedell Barry J.,Avants Brian,Zijdenbos Alex P.,Grand'Maison Marilyn,O’Neill Paul,O’Gorman John,Chen Tianle,Koeppe Robert

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference29 articles.

1. Use of Florbetapir-PET for Imaging β-Amyloid Pathology

2. Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab

3. Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

4. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

5. Efficacy, safety and biomarker data from SCarlet RoAD: a global Phase 3 study of gantenerumab in patients with prodromal AD;Lasser;Neurology.,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targets, trials and tribulations in Alzheimer therapeutics;European Journal of Pharmacology;2024-01

2. Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis;The Annals of Family Medicine;2024-01

3. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery;Expert Opinion on Drug Discovery;2023-11-10

4. Brain MRI to PET Synthesis and Amyloid Estimation in Alzheimer’s Disease via 3D Multimodal Contrastive GAN;Machine Learning in Medical Imaging;2023-10-15

5. Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans;mAbs;2023-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3